THE VACUTAINER® BRAND BLOOD COLLECTION SETS AND SAFETY-LOK™ BLOOD COLLECTION SET IS A WINGED BLOOD COLLECTION NEEDLE AND FLEXIBLE TUBING FOR VENIPUNCTURE TO COLLECT BLOOD SPECIMENS FROM PATIENTS OR MONITORING BLOOD PRESSURE. THE SAFETY-LOK™ BLOOD COLLECTION SET ALSO CONTAINS A NEEDLE SAFETY SHIELD WHICH MINIMIZES THE POSSIBILITY OF NEEDLESTICKS IF MANUALLY ACTIVATED FOLLOWING BLOOD COLLECTION. THE VACUTAINER® BRAND BLOOD COLLECTION SETS AND SAFETY-LOK™ BLOOD COLLECTION SET IS ALSO RECOMMENDED FOR USE IN PATIENTS WITH SMALL VEINS.

THE VACUTAINER® BRAND BLOOD COLLECTION SETS AND SAFETY-LOK™ BLOOD COLLECTION SET IS ALSO INDICATED FOR THE INTRAVENOUS ADMINISTRATION OF FLUIDS AND MAY BE USED FOR ANY PATIENT POPULATION WITH CONSIDERATION GIVEN TO PATIENT SIZE, APPROPRIATENESS FOR THE SOLUTION BEING INFUSED AND DURATION OF THERAPY.

Device Description

The VACUTAINER® Brand Blood Collection Sets and Safety-Lok™ Blood Collection Set is a sterile winged blood collection needles with flexible tubing and a female luer adapter manufactured by Becton Dickinson VACUTAINER Systems, Sumter, South Carolina. The Safety-Lok™ Blood Collection Set is provided with a safety shield for covering the used needle prior to disposal. A male fuer adapter is provided on specific reorder numbers. The male luer adapter contains a non-patient needle end for puncturing the stopper of an evacuated blood collection tube. Those without a male luer adapter are provided with a protective cap on the end of the female luer adapter.

AI/ML Overview

The provided document is a 510(k) Premarket Notification for the Becton Dickinson VACUTAINER® Brand Blood Collection Set and Safety-Lok™ Blood Collection Set. It primarily focuses on demonstrating substantial equivalence to predicate devices and describes the device's intended use and general characteristics.

Based on the available information, the document does not contain details about acceptance criteria, specific performance studies with quantifiable results against those criteria, or information on AI-related aspects.

Here's an analysis of the provided information in the context of your request:

A table of acceptance criteria and the reported device performance:
- N/A. The document states: "Biocompatibility of the VACUTAINER® Brand Blood Collection Set and Safety-Lok™ Blood Collection Set has been demonstrated in testing which was performed in accordance with the ISO 10993 Biological Testing requirements." and "Further, functional performance of the Safety-Lok™ Blood Collection Set has previously been demonstrated in 510(k) Premarket Notifications to the FDA."
- This indicates that performance testing was conducted, but the specific acceptance criteria and the quantitative or qualitative results against them are not included in this summary.
Sample sizes used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective):
- N/A. This information is not provided.
Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience):
- N/A. This information is not provided. The study is described as biocompatibility and functional performance testing, not a study requiring expert readers to establish ground truth.
Adjudication method (e.g., 2+1, 3+1, none) for the test set:
- N/A. This information is not provided.
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- N/A. This document predates widespread AI in medical devices (dated January 30, 1998). No MRMC or AI-assisted studies are mentioned.
If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- N/A. This document is for a physical medical device (blood collection set), not an algorithm or AI system.
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- N/A. The document mentions "Biocompatibility... in accordance with the ISO 10993 Biological Testing requirements" and "functional performance." For a physical device like a blood collection set, ground truth would typically be established by standardized physical/chemical tests, biological assays, and possibly direct observation of function (e.g., successful blood draw, secure safety mechanism activation). Specific details are not given.
The sample size for the training set:
- N/A. No training set for an algorithm is mentioned or relevant to this device.
How the ground truth for the training set was established:
- N/A. Not applicable, as there is no training set for an algorithm.

Summary of what the document does provide regarding studies:

Type of Study: Biocompatibility testing (in accordance with ISO 10993) and functional performance testing.
Purpose: To demonstrate the safety and effectiveness of the device and its substantial equivalence to predicate devices for regulatory approval.
Results Mentioned: Biocompatibility "demonstrated," and functional performance "previously demonstrated" in earlier 510(k) notifications. No specific data or acceptance criteria are detailed in this particular summary.

Summary

{0}------------------------------------------------

1420414

Becton Dickinson VACUTAINER Systems 1 Becton Drive Franklin Lakes, New Jersey 07417-1885 (201) 847-4500

MAR - 3 1998

SUMMARY OF SAFETY AND EFFECTIVENESS

I . GENERAL INFORMATION

This Summary of Safety and Effectiveness information is being submitted in accordance with the requirements of the SMDA of 1990 and 21 § 807.92

Establishment:

Becton Dickinson VACUTAINER Systems . Address: 1 Becton Drive Franklin Lakes, NJ 07417-1885
Registration Number: 2243072 ●
Contact Person: John A. Schalago ● Regulatory Affairs Specialist Telephone no .: 973 - 847 - 6280 Facsimile no .: 973 - 847 - 4858
. Date of Summary: January 30, 1998

Device Name:

。ブ

Trade Name: VACUTAINER® Brand Blood Collection Set
and Safety-LokTM Blood Collection Set
Classification Name: Accessory to: Tubes, Vials, Systems, Serum ● Separators, Blood Collection (75)KA)
Classification: Class II ●
Performance Standards: None Established under 514 of the Food, Drug and Cosmetic Act
II. Safety and Effectiveness Information Supporting the Substantial Equivalence Determination

Substantial Equivalence Declaration: The term "Substantial Equivalence" is used in this 510(k) Premarket Notification is limited to the

{1}------------------------------------------------

definition of Substantial Equivalence as found in the Federal Food, Drug, and Cosmetic Act, as amended and as applied under 21 CFR § 807, Subpart E under which a device can be marketed without pre-market approval or reclassification. A determination of substantial equivalency under this notification is not intended to have any bearing whatsoever on the resolution of patent infringement suits or any other patent matters. No statements related to, or in support of substantial equivalence herein shall be construed as an admission against interest under the US Patent Laws or their application by the courts.

· Device Description:
The VACUTAINER® Brand Blood Collection Sets and Safety-Lok™ Blood Collection Set is a sterile winged blood collection needles with flexible tubing and a female luer adapter manufactured by Becton Dickinson VACUTAINER Systems, Sumter, South Carolina. The Safety-Lok™ Blood Collection Set is provided with a safety shield for covering the used needle prior to disposal. A male fuer adapter is provided on specific reorder numbers. The male luer adapter contains a non-patient needle end for puncturing the stopper of an evacuated blood collection tube. Those without a male luer adapter are provided with a protective cap on the end of the female luer adapter.

Intended Use: .

The VACUTAINER® Brand Blood Collection Set and Safety-Lok™ Blood Collection Set are winged blood collection needles with flexible tubing and a female luer adapter intended for venipuncture to obtain blood samples from patients or monitoring blood pressure. The Safety-Lok™ Blood Collection Set is provided with a safety shield for covering the used needle prior to disposal. Some reorder numbers are provided with a male luer adapter. The male luer adapter contains a non-patient needle end for puncturing the stopper of an evacuated blood collection tube. Those without a male luer adapter are provided with a protective cap on the end of the female luer adapter.

The VACUTAINER® Brand Blood Collection Sets and Safety-Lok™ Blood Collection set is also indicated for the intravenous administration of fluids and may be used for any patient population with consideration given to patient size, appropriateness for the solution being infused and duration of therapy.

Synopsis of Test Methods and Results ●
Biocompatibility of the VACUTAINER® Brand Blood Collection Set and Safety-Lok™ Blood Collection Set has been demonstrated in testing which was performed in accordance with the ISO 10993

{2}------------------------------------------------

Biological Testing requirements. Further, functional performance of the Safety-Lok™ Blood Collection Set has previously been demonstrated in 510(k) Premarket Notifications to the FDA.

Substantial Equivalence ●
Becton Dickinson VACUTAINER Systems believes that the VACUTAINER® Brand Blood Collection set and VACUTAINER® Brand Safety-Lok™ Blood Collection set are substantially equivalent to the predicate devices described below. This substantial equivalence determination is supported by a comparison of device components, intended use and function.

Manufacturer		Number
Becton DickinsonInfusion Therapy systems	E-Z Set®IntravascularAdministration Set	K970259	April 8, 1997
Becton DickinsonInfusion Therapy systems	Safety E-Z Set®IntravascularAdministration Set	K970259	April 8, 1997

John A. Schalago

Regulatory Affairs Specialist Regulatory Affairs Department

1/30/98

Date

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings.

MAR - 3 1998

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

John Schalago Regulatory Affairs Specialist Becton Dickinson 1 Becton Drive Franklin Lakes, New Jersey 07417-1885

Re : K980414 VACUTAINER® Brand Blood Collection Set and Safety-Lok™ Blood Collection Set Requlatory Class: II Product Code: JKA Dated: January 30, 1998 Received: February 3, 1998

Dear Mr. Schalago:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does

not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or requlations.

{4}------------------------------------------------

Page 2

Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770) 488-7655.

This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,
Steven Aitman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radioloqical Health

Enclosure

{5}------------------------------------------------

510(K) NUMBER (IF KNOWN): J

DEVICE NAME: VACUTAINER® BLOOD COLLECTION SET AND SAFETY-LOKTM BLOOD COLLECTION SET

INDICATIONS FOR USE:

(Division Sign-Off)
Division of Clinical Laboratory Devices
510(k) Number 980414

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use
------------------	----------------------------

Over-the-Counter Use

(Per 21 CFR § 801.109)

(Optional format 1-2-96) ,

Page 39

Regulation Number and Section

§ 862.1675 Blood specimen collection device.

(a)
Identification. A blood specimen collection device is a device intended for medical purposes to collect and to handle blood specimens and to separate serum from nonserum (cellular) components prior to further testing. This generic type device may include blood collection tubes, vials, systems, serum separators, blood collection trays, or vacuum sample tubes.(b)
Classification. Class II.